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Abstract
Background: The rising epidemic of obesity is associated with cognitive decline and is considered as one of the
major risk factors for neurodegenerative diseases. Neuroinflammation is a critical component in the progression of
several neurological and neurodegenerative diseases. Increased metabolic flux to the brain during overnutrition
and obesity can orchestrate stress response, blood-brain barrier (BBB) disruption, recruitment of inflammatory
immune cells from peripheral blood and microglial cells activation leading to neuroinflammation. The lack of an
effective treatment for obesity-associated brain dysfunction may have far-reaching public health ramifications,
urgently necessitating the identification of appropriate preventive and therapeutic strategies. The objective of our
study was to investigate the neuroprotective effects of Momordica charantia (bitter melon) on high-fat diet (HFD)-
associated BBB disruption, stress and neuroinflammatory cytokines.
Methods: C57BL/6 female mice were fed HFD with and without bitter melon (BM) for 16 weeks. BBB disruption
was analyzed using Evans blue dye. Phosphate-buffered saline (PBS) perfused brains were analyzed for
neuroinflammatory markers such as interleukin-22 (IL-22), IL-17R, IL-16, NF-B1, and glial cells activation markers
such as Iba1, CD11b, GFAP and S100b. Additionally, antioxidant enzymes, ER-stress proteins, and stress-resistant
transcription factors, sirtuin 1 (Sirt1) and forkhead box class O transcription factor (FoxO) were analyzed using
microarray, quantitative real-time RT-PCR, western immunoblotting and enzymatic assays. Systemic inflammation
was analyzed using cytokine antibody array.
Results: BM ameliorated HFD-associated changes in BBB permeability as evident by reduced leakage of Evans blue
dye. HFD-induced glial cells activation and expression of neuroinflammatory markers such as NF-B1, IL-16, IL-22 as
well as IL-17R were normalized in the brains of mice supplemented with BM. Similarly, HFD-induced brain oxidative
stress was significantly reduced by BM supplementation with a concomitant reduction in FoxO, normalization of
Sirt1 protein expression and up-regulation of Sirt3 mRNA expression. Furthermore, plasma antioxidant enzymes and
pro-inflammatory cytokines were also normalized in mice fed HFD with BM as compared to HFD-fed mice.
Conclusions: Functional foods such as BM offer a unique therapeutic strategy to improve obesity-associated
peripheral inflammation and neuroinflammation.
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The rising epidemic of obesity is associated not only with
diabetes and cardiovascular diseases, but also brain dys-
function and early onset of dementia [1]. High-fat diet
(HFD) induces pro-inflammatory cytokines including
tumor necrosis factor a (TNFa), interleukin (IL-1b)a n d
IL6 in peripheral tissues as well as hypothalamus, raising
the possibility of a cross-talk between peripheral and neu-
roinflammation [2,3]. Negative impact of increased body
mass on brain and its function is evident from impaired
cognition [4], a lower brain volume [5], increased lesions
of the white matter [6], temporal lobe atrophy [7], and
Alzheimer-type neuropathological changes [8] among
obese individuals. In rodents, diet-induced obesity com-
promises spatial learning skill [9], reduces hippocampus
plasticity [10], and contributes to the development of Alz-
heimer’s disease (AD) [11]. Although the underlying
mechanisms remain unclear, stress and neuroinflamma-
tion have been implicated to play a major role in diet-
induced brain dysfunction [12,13].
Regardless of our present knowledge involving cellular
pathways that modulate obesity-associated neurodegen-
erative diseases, complete therapeutic prevention or
reversal of acute or chronic neuronal injury remains elu-
sive. Therapeutic and preventive strategies to reduce
obesity require multiple therapies and life-style changes
that may not necessarily ameliorate neuronal insults.
Interestingly, Okinawan centenarians demonstrate nor-
mal cognitive function such as attention span and mem-
ory, and delayed onset of dementia, which was
associated with various life-style factors including con-
sumption of bitter functional foods [14,15].
Our study investigates the neuroprotective effects of
Momordica charantia (bitter melon, BM), a staple of
traditional Okinawan diet, to ameliorate obesity-asso-
ciated neuroinflammation and stress. BM is widely culti-
vated in Asia, Africa and South America and extensively
used in Ayurvedic and Chinese medicines as a remedy
for diabetes and its complications including neuropathy
[16]. We and others have demonstrated that BM
reduces adiposity in rodents fed a HFD, lowers plasma
and hepatic lipids, insulin and leptin levels and nor-
malizes glucose tolerance [17-19]. Furthermore, BM has
been demonstrated to lower systemic oxidative stress in
streptozotocin-induced diabetic rats [20] as well as
proinflammatory interleukins in lipopolysaccharide
(LPS)-stimulated murine peritoneal macrophages [21].
We therefore tested the hypothesis that BM will lower
HFD-associated systemic inflammation as well as neu-
roinflammation and oxidative stress.
Our data suggests that BM attenuated HFD-induced
BBB disruption and mRNA expression of neuroinflam-
matory cytokines such as IL22, IL16 and NF-B1 with a
concomitant reduction in oxidative stress in brains of
mice fed HFD for 16 weeks. Amelioration of HFD-asso-
ciated neuroinflammation by BM was accompanied by
increased expression of sirtuin 1 (Sirt1) transcripts and
reduction of forkhead box class O transcription factor
(FoxO) mRNA, known to regulate oxidative stress and
inflammation. Furthermore, BM attenuated plasma oxi-
dative stress markers and peripheral inflammation, spe-
cifically modulating Th1 vs Th2 immune response and
possibly activating Th17 lymphocytes. BM also reduced
circulating plasma cytokine levels including monocyte
chemoattractant protein 1 (MCP1), macrophage colony-
stimulating factor (M-CSF), and macrophage inflamma-
tory protein-1a (MIP-1a) that are involved in either dis-
rupting the blood-brain barrier (BBB) or inducing
chemotaxis of T lymphocytes and monocytes in vascular
endothelial cells of the BBB [22-24]. Overall, functional
foods such as BM offer unique possibilities to ameliorate
not only obesity and type 2 diabetes (T2D), but also may
simultaneously prevent and/or delay onset of obesity-
associated systemic inflammation, neuroinflammation
and stress.
Methods
Preparation of BM
Details of BM preparations have been described pre-
viously [19]. In brief, Chinese variety of young BM (raw
and green) was obtained from local farmer’sm a r k e t ,
juiced using a household juicer, freeze dried at -45°C for
72 h and stored at -80°C until used for feeding studies.
The Chinese BM was verified and identified by ethnobo-
tanist, Dr. Will McClatchy (Professor, Dept. of Botany,
University of Hawaii) and voucher specimens were
deposited at official herbaria, University of Hawai’ia t
Manoa, herbarium (HAW), and labeled as Pratib-
haBM0001 and PratibhaBM0002.
Animal studies
All animal experiments and procedures were conducted
in accordance with guidelines established by the
National Institutes of Health and the University of
Hawaii Institutional Animal Care and Use Committee.
Four- to six -weeks old female C57BL/6 mice were pur-
chased from Jackson Laboratories (Ann Harbor, MI)
and randomized in four groups of eight animals each: 1)
control, 2) control diet + 1.5% freeze dried BM (w/w),
3) HFD, and 4) HFD + 1.5% freeze dried BM (w/w).
Brains from four animals of each group were used for
biochemical analysis. Details of animal experiment and
diets have been described previously [19]. In a separate
set of experiments, four animals were used to analyze
the BBB permeability. As published earlier, control
rodent chow contained 11 kcal% fat (4.07 kcal/g,
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HFD chow contained 58 kcal% fat (5.6 kcal/g, # D12331,
Research Diets) [19]. Freeze dried BM juice was mixed
with diet at 1.5%, w/w. Macronutrient analysis demon-
strated that lyophilized BM extract contained 24% pro-
tein and 2% fat [19]. However, changes in protein,
carbohydrate or fat content of the diet were negligible
with addition of 1.5% (w/w) BM. Therefore the compo-
sition of control or HFD diet was not modified. Addi-
tion of BM did not significantly change either the
carbohydrate or mineral content of the diet, based on
the macronutrient chemical analysis data published ear-
lier [19]. Food and water was provided ad libitum. Food
intake and body weights were measured daily while
water intake was measured weekly as described pre-
viously [19]. After 16 weeks, mice were anesthetized
using 2% Attane™ isoflurane (Minrad Inc, Bethlehem,
PA) under 2 LPM oxygen, using OHMEDA Isotec 4
Vaporizer (Datex-Ohmeda, Helsinki, Finland). Animals
were perfused with ice-cold phosphate-buffered saline
(PBS) to flush off blood from the brain and other
organs. Whole brains were isolated after euthanasia,
washed in PBS and immediately snap frozen in liquid
nitrogen and were stored at -80°C until further analysis.
Determination of BBB permeability
Influence of HFD and BM on BBB permeability was
determined by measuring Evans blue dye transport
across the BBB according to published protocols [25,26].
In brief, Evans blue dye (50 mg/kg) was injected intra-
peritoneally. After 3 h, mice were anesthetized and per-
fused with PBS. Brains were quickly dissected and snap
frozen in liquid nitrogen. Right brain was crushed on
dry ice and the powder was homogenized with Bullet
Blender (Next Advance, Inc., Averill Park, NY) in one
mL of 50% trichloroacetic acid (TCA, wt/vol) using 0.5
mm stainless steel beads (Next Advance, Inc.) for 90
seconds. Homogenates were centrifuged at 10,000 rpm
for 20 minutes. The supernatant was diluted with 100%
ethanol (1:2) and 200 μl was added to 96-well black
plates. Fluorescence was monitored using Wallac Victor
2
1420 Multilabel Counter (PerkinElmer Life Sciences,
Boston, MA) at 620-nm excitation and 680-nm emis-
sion. Total dye was calculated based on external stan-
dards (10 -1000 ng/mL) dissolved in 50% TCA/ethanol
(1:3).
RNA extractions
Frozen left brains were powdered to obtain a homoge-
nous sampling and 30 to 40 mg of whole brain was
homogenized using PRO 200 Laboratory Homogenizer
(Pro Scientific, Oxford, CT) followed by the QIAshred-
der (Qiagen, Inc., Valencia, CA, Cat#: 79656). RNA was
extracted using the RNeasy Mini Kit (Qiagen, Inc., Cat#:
74104) as per the manufacturers’ protocol. The quality
of RNA was tested using Agilent bioanalyzer at the
Greenwood Molecular Biology Facility, Pacific Bios-
ciences Research Center, University of Hawaii at Manoa
(UHM). The 18S/28S ratios of all samples were in the
range of 1.8 to 2.0.
Genome-wide microarray analysis
Transcriptional profiling of mouse brain was conducted
using Affymetrix GeneChip Mouse Genome 430 2.0
Array (Affymetrix, Inc., Santa Clara, CA. Part#: 900497)
according to the standard GeneChip eukaryotic target
labeling protocol (Affymetrix, Inc.), at the Greenwood
Molecular Biology Facility, UHM. All subsequent
manipulations, including labeling and hybridization,
were performed independently for each sample. Briefly,
10 μg of total cellular RNA per sample was used to
synthesize double-stranded cDNA, which then was tran-
scribed in vitro i nt h ep r e s e n c eo fb i o t i n y l a t e dd N T P s
(Enzo Diagnostics, Farmingdale, NY). Successful labeling
of all the samples was tested by test array hybridizations,
using the Affymetrix GeneChip Test3 Array (Affymetrix,
Inc., Part#: 900341), to ensure quality of the biotinylated
target. Appropriate internal controls were added to the
hybridization cocktail. Gene chip arrays were scanned at
570 nm with a gene array scanner and analyzed with
Gene Chip Operating Software (GCOS) v1.4 (Affyme-
trix, Inc.). The method of normalization used was a scal-
ing algorithm, which involves multiplying the mean
intensity of each chip (not including the upper and
lower 2%) by a factor, which changes the mean intensity
to 500 for every chip. By scaling each chip, a direct
comparison could be made between all the chips. For a
given gene transcript in any chip-to-chip comparison
GCOS generates a Change Call parameter Increase or
Decrease based on a consideration of signal specificity as
well as intensity. The Change Call i sb a s e do na ne v a -
luation of the intensities of the signals generated from
each gene transcript on one chip relative to the corre-
sponding signal intensities on the other chip. The data
were filtered using Genespring 9.0 software, based on
both “Detection Call” (presence or absence) and “Signal
Log Ratio” (1.5-fold change or greater) in any of the
comparisons between control and various treatment
groups. In the case of the Affymetrix Detection Call
algorithm, genes that were “Absent” in all samples were
filtered out. Genes had to be detected or “Present” in at
least one out of four treatment groups.
Validation of selected genes by real-time RT-PCR
To confirm changes in the expression of selected genes,
RNA samples from four mice in each treatment group,
including those analyzed by microarray, were assayed by
quantitative real-time reverse transcriptase-PCR (qRT-
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CA). In brief, one μg of total RNA was used for cDNA
synthesis (iScript cDNA Synthesis Kit, Bio-Rad, Her-
cules, CA) as described previously [27]. qRT-PCR was
conducted by using two μLo fd i l u t e dc D N A( 1 :3 )i n
duplicate with both internal and no template controls.
Primer sequences used for amplification of specific
genes were designed using the Beacon Designer 2.0 pri-
mer design software (PREMIER Biosoft International,
Palo Alto, CA, Table 1). A SYBR Green detection sys-
tem was used and the reactions generated a melting
temperature dissociation curve enabling quantitation of
the PCR products. The housekeeping gene GAPDH,
whose expression was unaffected by HFD, was used as
an internal control for normalization in parallel with
each gene of interest. PCR cycling conditions were 95°C
for 5 min, 45 cycles of 95°C for 10 sec, 54°C for 45 sec
except for Eif3s10 (95°C for 5 min, 45 cycles of 95°C for
10 sec, 56°C for 45 sec), and the melt curve beginning
at 55°C of 80 cycles and gradually increasing 0.5°C every
10 sec. To verify reproducibility, each brain sample was
analyzed in duplicate in two independent experiments
for each gene. PCR product intensity data were normal-
ized to GAPDH and relative fold-change was obtained
using the ΔΔCt equation calculated by the Bio-Rad iQ5
software.
Brain superoxide dismutase activity
Brain homogenates were prepared in 10 volumes of ice-
cold HEPES buffer (20 mM HEPES, 1 mM EGTA, 210
mM mannitol, 70 mM sucrose, pH 7.2) and centrifuged
at 1,500 × g for 5 min. The supernatant was further
centrifuged at 10,000 X g for 15 min. The resulting
supernatant contained the cytosolic superoxide dismu-
tase (SOD), and the pellet containing the mitochondrial
SOD was resuspended in HEPES buffer. Both fractions
were frozen at -80°C for up to one month, and cytosolic
(Cu/ZnSOD) and mitochondrial SOD (MnSOD) activ-
ities were analyzed using commercial Superoxide Dis-
mutase Assay kit (Cayman Chemicals, Ann Arbor, MI).
Brain catalase activity
Brain homogenates (20% w/v) were prepared in ice-cold
phosphate buffer containing 50 mM potassium phos-
phate, pH 7.0 containing 1 mM EDTA and centrifuged
at 10,000 X g for 15 min at 4°C. The supernatants were
collected and stored at -80°C until analysis for up to
one month. Catalase activity was assayed using commer-
cial Catalase kit according to manufacturers’ protocol
(Cayman Chemicals).
Brain glutathione peroxidase (GPx) activity
A 10% brain homogenate was prepared in ice-cold buf-
fer containing 50 mM Tris-HCl, pH 7.6, containing 5
mM EDTA and 1 mg/mL BSA and centrifuged at
10,000 X g for 15 min at 4°C. Supernatants were col-
lected and frozen at -80°C until analysis for up to one
month. GPx activity was measured using commercial
GPx kit according to the manufacturers’ protocol (Cay-
man Chemicals).
Brain GSH levels
Total brain GSH was measured according to published
protocol [28] with modifications [29]. In brief, a 20% w/
v homogenate was prepared from frozen brain using
phosphate buffer containing 100 mM sodium phosphate,
pH 8.3, and 5 mM EDTA. Homogenates were centri-
fuged at 10,000 X g for 15 min and supernatants were
deproteinated with an equal volume of 10% trichloroa-
cetic acid and frozen at -80°C until analysis. The final
reactions were performed in a 96-well plate by incubat-
ing deproteinated brain homogenates, phosphate buffer
and o-phthalaldehyde solution in a total volume of 200
μL. Fluorescence was monitored at 350/420 in the Wal-
lac Victor
2 1420 Multilabel Counter (PerkinElmer Life
Sciences) and values were compared to GSH standard
curve freshly prepared with each batch of samples and
adjusted to μM GSH/g brain.
Analysis of glial cell activation
Ionized calcium-binding adapter molecule 1 (Iba1) and
integrin aM (CD11b) mRNA expression, were measured
to analyze microglial cells activation, whereas glial fibril-
lary acidic protein (GFAP) and calcium binding protein,
beta (S100b), mRNA expression were measured to
quantitate astrocyte activation. mRNA was analyzed by
qRT-PCR as mentioned above, using primers and condi-
tions described in Table 1.
Iba1 and GFAP protein levels were analyzed by wes-
tern blotting. Whole cell proteins were extracted by pre-
paring a 5% homogenate in ice-cold buffer containing
10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM
EDTA, 1 mM EGTA, 100 mM NaF, 150 mM sodium
pyrophosphate, 2 mM sodium orthovanadate, 2 mM
PMSF and protease inhibitor (Roche Diagnostics Cor-
poration, Indianapolis, IN), using PRO 200 Laboratory
Homogenizer (Pro Scientific). Homogenates were centri-
fuged at 12,000 RPM at 4°C for 20 min and superna-
tants were stored at -80°C until further analysis. Protein
concentrations were determined using Bradford protein
assay reagent according to the manufacturers’ instruc-
tions (Bio-Rad Laboratories, Hercules, CA, USA). Forty
μg of whole cell proteins were electrophoresed on a
NuPage 4-12% gradient, Bis-Tris gel (Invitrogen, Carls-
bad, CA) and were transferred on to nitrocellulose
membranes. The membranes were blocked with Li-Cor
blocking solution (Li-Cor Biosciences, Lincoln, NE),
incubated overnight with either polyclonal rabbit anti-
Nerurkar et al. Journal of Neuroinflammation 2011, 8:64
http://www.jneuroinflammation.com/content/8/1/64
Page 4 of 19Iba1 (Wako Chemicals, Richmond, VA), anti-GFAP anti-
bodies (Dako, Carpinteria, CA) or monoclonal mouse
anti-b-actin (Sigma Chemicals, St. Louis, MO), washed
and probed with secondary antibodies, IRDye 680LT
conjugated Goat (polyclonal) anti-Mouse IgG (H+L) or
IRDye 800CW conjugated Goat (polyclonal) anti-Rabbit
IgG (H+L) (Li-Cor Biosciences). Membranes were kept
moist and protected from light. Proteins were visualized
and membranes were scanned using Odyssey Infrared
Imaging System using Odyssey channel 800 for anti-
Rabbit (green fluorescence) and channel 700 for anti-
Mouse (red fluorescence) (LiCor Biosciences).
Analysis of Sirt1 protein by western immunoblotting
Twenty μg of whole cell proteins were electrophoresed
on 8% polyacrylamide gels and were transferred on to
Table 1 Primer sequences for real-time RT-PCR
Target Gene
(GenBank Acc. No.)
Primer Sequence Amplicon size (bp)
IL-22 (AJ249492)
Forward
Reverse
5’-GTGACGACCAGAACATCCAG-3’
5’-ATCTCTCCGCTCTCTCCAAG-3’
76
IL-17rb (NM_019583)
Forward
Reverse
5’-CTGTGTGGAGGTAGTGCTATG-3’
5’-CTCAGGCGTGTATGCTCAG-3’
78
NF-B (AK011965)
Forward
Reverse
5’-CGTCGGTGCTATTCTGTTG-3’
5’-GCTGTCTGGTAAAGGTTGTTC-3’
76
IL-16 (BC026894)
Forward
Reverse
5’-AGGAAAGCAAGATGGAGGAC-3’
5’-GAGGAGTTAGGGAAGGTTGTG-3’
116
Aif1/Iba1 (NM_019467.2)
Forward
Reverse
5’-GTCCTTGAAGCGAATGCTGG-3’
5’-CATTCTCAAGATGGCAGATC-3’
157
CD11b (NM_019467)
Forward
Reverse
5’- CAGGCATCACTTCCACATCAGC-3’
5’- CTGTCTTAACCTGCATCA-3’
174
GFAP (NM_10277)
Forward
Reverse
5’- TCTCCTCCTCCAGCGATTCAAC-3’
5’- TGTGGATTTGGAGAGAAA-3’
78
S100B (NM_009115)
Forward
Reverse
5’- CTGCTTGCCATCTGCCTGAG-3’
5’- GAGGTTGCTCATCCTTAC-3’
134
Eif3s10 (AW701127)
Forward
Reverse
5’-CTCTTCAGTCCGGTCATCTTTC-3’
5’-CAAGTCGCCGTGATGATAGG-3’
194
Hsp110 (D67017)
Forward
Reverse
5’-AATGAGAAGGGCTCTGTCAAC-3’
5’-CAGGATCACATACTATGGCAAAC-3’
96
Dnajb1 (AK002290)
Forward
Reverse
5’-AGTGGTGGTGCTAATGGTAC-3’
5’-AAAAGGTATCAAAGGGGTTTCTG-3’
103
Dnaja3 (AK004575)
Forward
Reverse
5’-AGATGGTCAGACTGTAAGGATG-3’
5’-AGAGGTCCGAGTGGATGTC-3’
113
Sirt3 (NM_022433)
Forward
Reverse
5’-CTGGATGGACAGGACAGATAAG-3’
5’-TCTTGCTGGACATAGGATGATC-3’
79
Foxo1 (AI462296)
Forward
Reverse
5’-ACGGGCTGTCTGTCTGTC-3’
5’-TAAGTGAAGTTTCTCTGTGGTTTC-3’
116
Foxo3a (BB364488)
Forward
Reverse
5’-GCCTCGGTCACACTCCAG-3’
5’-TTCACACCTGTCCACATTTCC-3’
166
GAPDH (NM_001001303)
Forward
Reverse
5’-TCAACGGCACAGTCAAGG-3’
5’-ACTCCACGACATACTCAG-3’
126
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blocked with 5% milk, incubated overnight with polyclo-
nal rabbit anti-Sirt antibody (Upstate, Millipore, Biller-
ica, MA), washed and probed with a secondary donkey
anti-rabbit IgG (Santa Cruz Biotechnology, Santa Cruz,
CA) conjugated to horseradish peroxidase (Santa Cruz
Biotechnology). Blots were stripped using ReBlot Plus
mild stripping solution (Millipore, Billerica, MA) and
probed for b-actin using monoclonal b-actin (Sigma
Chemicals, MO) and goat anti-mouse IgG (Santa Cruz
Biotechnology) antibodies. Proteins were visualized
using commercially available electrochemiluminescence
kit (Amersham Biosciences, Piscataway, NJ, USA). Pro-
tein bands were scanned using the Molecular Imager
Gel Doc XR System (Bio-Rad) and intensities were ana-
lyzed using the Discovery Series Quantity One 1-D Ana-
lysis Software (Bio-Rad).
Analysis of plasma antioxidant and inflammation markers
Plasma SOD, catalase, GPx and GSH levels were ana-
lyzed as mentioned above. Systemic inflammation was
analyzed by measuring plasma cytokine levels using the
RayBio Mouse Cytokine Antibody Array 3 (RayBiotech
Inc., Norcross, GA). The assay employs a qualitative dot
blot technique. The standard array matrix consisted of a
14 × 10 dot grid on a nitrocellulose membrane with 62
unique antibodies. Assay was conducted as per the man-
ufacturers’ protocol. Briefly, membranes were individu-
ally placed in chambers of eight-well tissue culture
plates and blocked with the blocking buffer provided by
the manufacturer. After blocking, membranes were
incubated for 2 hr with 1:10 diluted plasma using block-
ing buffer supplied by the manufacturer. The mem-
branes were then incubated with biotin-conjugated
antibodies for 2 hr and horse radish peroxidase conju-
gated streptavidin for 1 hr. Proteins were visualized
using SuperSignal West Pico enhanced chemilumines-
cent solution (Thermo Scientific, Rockford, IL, CA,
USA). Protein bands were scanned using the Molecular
Imager Gel Doc XR System (Bio-Rad) and intensities
were analyzed using the Discovery Series Quantity One
1-D Analysis Software (Bio-Rad). Intensities of positive
controls were used to normalize the results from differ-
ent membranes. All membranes were processed and
developed simultaneously to minimize variability.
Chemical analysis to quantitate major polyphenols of BM
extract
Phenolic constituents of BM extracts were determined by
LC-MS analyses, using a triple quad and a time of flight
analyzer. In brief, one gram of powder, derived from the
freeze-dried BM juice, was extracted with 50 mL of
methanol for 30 min using an ultrasound water bath.
The mixture was filtered to remove the particulates, and
the solvent was evaporated in a rotary evaporator at 30°C
yielding 233 mg of dry extract. The residue was re-dis-
solved in 5 mL of LCMS grade methanol and filtered
through a 0.22 micron syringe filter. The solution was
transferred into a LCMS vial and 1 μL was injected into
the LC-QQQ-MS instrument for quantitative analysis
carried out using an 6400 QQQ-MSD instrument con-
nected to an Agilent 1200 LC system (Agilent Technolo-
gies, Foster City, CA). Chromatographic analysis was
performed on an Zorbax XDB C18 column (1.8 μm, 4.6
× 50 mm, Agilent Technologies) using a gradient of 10-
100% acetonitrile containing 0.01% formic acid and water
containing 5 mM ammonium formate with 0.01% formic
acid over 15 minutes (flow rate 1 mL/min). The column
was heated to 40°C. For quantitative analysis the QQQ
instrument was operated in dynamic MRM mode using
an ESI ion source with capillary voltage at 2500 V. The
gas temperature was kept constant at 350°C with a gas
flow of 12 L/min. Nebulizer gas pressure was set to 30
psi. Standard solutions (10 μg/mL) of caffeine, trans-chal-
cone, flavone, caffeic acid, catechin, quercetin and gallic
acid were prepared in methanol and calibration curves
were generated using injection volumes of 0.1, 0.2, 0.5,
and 1 μL. Quantitation was conducted using the Mas-
shunter Workstation Qualitative and Quantitative Analy-
sis software version B.01.03 (Agilent Technologies). High
resolution TOFMS data (1 μL injection) was recorded on
a 6210 LC/MSD-TOF instrument equipped with an 1100
chromatography module (Agilent Technologies). The
TOF instrument was operated with a capillary voltage of
4500 V, a gas temperature of 300-350°C with a flow rate
of 10 L/min and a nebulizer pressure of 30 psi. Chroma-
tographic conditions and data analysis were conducted as
described above for quantitative analysis.
Statistical analysis
Statistical analysis was conducted using GraphPad
Prism, Prism 5 for Windows, version 5.01. All data were
expressed as mean values ± SEM. A one-way ANOVA
model was used to compare means between the three
animal groups (control, HFD and HFD + BM). For each
sample, duplicate determinations were conducted. Post
hoc pair-wise multiple comparisons were evaluated
using the Tukey’s Multiple Comparison test, after
ANOVA. Results were considered significant at p < 0·05.
Results
BM modulates metabolic parameters
We have previously demonstrated that BM has no sig-
nificant effect on food or water intake, reduced overall
weight gain by 21% as compared to mice fed HFD with
a concomitant reduction in hepatic and plasma lipids
and improvement in glucose tolerance [19]. The brain
samples used in the current study were obtained from
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Although epidemiological observations suggest an effect
of obesity on brain volume reduction, our animal studies
indicated no difference in the brain weights among the
different treatment groups (data not shown).
BM prevents HFD-induced leakage of Evans blue dye
Figure 1A demonstrates a significant increase (p < 0.05)
in the amount of Evans blue dye in the brains of mice
fed HFD for 16 weeks as compared to control. BM nor-
malized the amount of Evans blue dye in brains of mice
fed HFD with BM (Figure 1A).
Microarray analysis of whole brain mRNA expression
Out of 39,000 transcripts, more than 4,000 genes were
differentially regulated by HFD, out of which 1,100
genes were up-regulated and 1,200 genes were down-
regulated by 2-fold or more (data not shown). An inde-
pendent manuscript is being prepared depicting the glo-
bal overview of results and categorizing significant
pathways of metabolic and cellular functions. The pri-
mary focus of this manuscript is to investigate the
effects of BM on pro-inflammatory cytokines and mole-
cules regulating cellular stress pathways. Table 2
demonstrates fold-change of selected gene expression
involved in stress, inflammation, and transcription/sig-
naling, in the brains of mice fed either HFD or HFD
and BM, as compared to mice fed control diet. Expres-
sions of selected genes were validated by measuring
qRT-PCR, enzyme activities or western immunoblotting.
Preliminary studies with Sirt1 expression demonstrated
that trends of mRNA expression and protein levels were
similar. Since the quantity of brain tissue available for
testing was limited, we analyzed the remainder of the
molecules by measuring only mRNA expression.
BM protects brain from HFD-induced neuroinflammation
HFD-induced neuroinflammation is characterized by
BBB disruption, transmigration of activated lymphocytes
as well as activation of microglial cells by infiltrating
immune cells leading to increased production of pro-
inflammatory cytokines such as IL-16 [30,31]. In the
present study, we observed a 10-fold up-regulation of
IL-22 mRNA expression (Figure 1B, p < 0.05) along
with a significant up-regulation of IL-17R expression by
177% (Figure 1C, p < 0.05) in the brains of mice fed
HFD. However, the 10-fold increase in IL-22 mRNA
expression detected by qRT-PCR was lower than the 16-
fold increase observed by microarray analysis (Table 2).
HFD also significantly up-regulated the mRNA expres-
sion of NF-B1, a “master inflammatory switch” and
activator of microglial cells, by 156% as compared to
control mice, which was normalized in mice fed HFD
with BM (Figure 1D, p < 0.05). Feeding HFD for 16
weeks, increased IL-16 mRNA expression by 10-fold as
indicated by microarray analysis (Table 2) and 24-fold
b yq R T - P C R( F i g u r e1 E ,p<0 . 0 5 ) .B o t h ,I L - 2 2a n dI L -
16 were absent in the brains of control mice and those
fed with HFD with BM (Figure 1B and 1E, respectively).
Activation of microglial cells by HFD was indicated by
modest, but significant upregulation of Aif1/Iba1 and
CD11b mRNA levels by 140-150% as compared to con-
trol, (Figures 2B and 2C, respectively, p < 0.05). Simi-
larly, mRNA expression of GFAP and S100B were also
up-regulated by 140-150% above that of control, indica-
tive of astrocyte activation (Figures 2E and 2F, respec-
tively, p < 0.05). Interestingly GFAP proteins were up-
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Figure 1 Effect of HFD and BM on blood-brain barrier
permeability and neuroinflammatory markers. Concentrations of
Evans blue dye (A) and mRNA expression of IL-22 (B), IL-17R (C), NF-
B1 (D) and IL-16 (E) in brains of mice fed HFD with and without
BM. Values represent the mean ± SE (n = 4). Each sample was
analyzed in duplicate, in two independent experiments.
a,b,cMean
values with common letters do not differ (p < 0·05).
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Page 7 of 19regulated by more than 300% above that of control in
contrast to a modest 174% increase in Iba1 protein
levels above that of control (Figures 2D and 2A, respec-
tively, p < 0.05). Although the exact mechanisms remain
unclear, BM inhibited markers of glial cells activation
(Figure 2) and normalized the cytokine expression of IL-
17R, IL-16, IL-22 and NF-B1 in brains of mice fed
HFD (Figure 1), suggesting an anti-neuroinflammatory
effect in these mice.
BM attenuates HFD-induced oxidative stress in brain
Figure 3 demonstrates the effect of BM on HFD-
induced oxidative stress in whole brain as measured by
antioxidant enzyme levels. HFD significantly induced
mitochondrial MnSOD enzyme activity by 78% as
compared to control (Figure 3A, p < 0.05), while 24%
induction of CuZnSOD was not significant (Figure 3B,
p > 0.05), as compared to control mice. BM normalized
the MnSOD activity (Figure 3A), but significantly
reduced CuZnSOD activity as compared to both, HFD-
fed and control mice (Figure 3B, p < 0.05). Hydrogen
peroxide generated by increased ROS production is
detoxified by either catalases (CAT) or GPx. In our
study, both catalase (Figure 3C) and GPx (Figure 3D)
were reduced by 54% and 40%, respectively, in HFD-fed
mice, both of which were normalized in mice fed HFD
with BM. However, changes in catalase and GPx failed
to achieve significance due to large sample variability.
The CAT/MnSOD ratio was significantly reduced by
75% in the brains of HFD-fed mice compared to con-
trol, while simultaneous feeding of BM increased the
CAT/MnSOD ratio by 131% as compared to control
and by more than 500% as compared to HFD-fed mice
(Figure-3E, p < 0.05). In contrast, HFD non-signifi-
cantly reduced GPX/MnSOD ratios by 68% (Figure 3F).
BM normalized the brain GPX/MnSOD ratios as com-
pared to control mice, but significantly up-regulated
the ratios by 323% compared to HFD-fed mice (Figure
3F, p < 0.05). Furthermore, the ratios of CAT/total
SOD (sum of MnSOD and CuSOD) were insignificantly
r e d u c e di nb r a i no fH F D - f e dm i c ea sc o m p a r e dt oc o n -
trol (data not shown) but significantly reduced by 80%
compared to mice fed HFD with BM (data not shown).
Overall, ratios of GPX/total SOD were non-significantly
reduced in brains of HFD-fed mice compared to con-
trol and those fed HFD with BM (data not shown). BM
also up-regulated HFD-associated reduction in brain
GSH levels (Figure 3G).
Table 2 Changes in brain gene expression of C57BL/6 female mice fed HFD ± BM
Gene Name Symbol Con HFD HFD + BM
Sirtuin 1 Sirt1 1.0 0.86 0.88
Sirtuin 3 Sirt3 1.0 0.72 1.28
Sirtuin 7 Sirt7 1.0 0.99 1.14
Forkhead box O3a Foxo3a 1.0 2.92 1.32
Forkhead box O1 Foxo1 1.0 0.65 0.5
Superoxide dismutase 2, mitochondrial Sod2 1.0 1.32 1.48
Glutathione S-transferase, pi 1 Gstp1 1.0 0.76 1.03
Glutathione peroxidase 4 Gpx4 1.0 0.9 1.10
*Interleukin 10 Il10 1.0 1.76 Absent
*Interleukin 16 Il16 1.0 16.06 Absent
*Interleukin 22 Il22 1.0 10.80 Absent
*Interleukin 17 receptor B Il17rb 1.0 0.597 Absent
*Nuclear factor of kappa B1 NfB1 1.0 8.22 Absent
Eukaryotic translation initiation factor 2, subunit 2 (beta) Eif2s2 1.0 0.77 1.03
Eukaryotic translation initiation factor 2B, subunit 2 beta Eif2b2 1.0 0.90 1.04
Eukaryotic translation initiation factor 2, subunit 3, structural gene X-linked Eifs3x 1.0 0.79 1.2
Eukaryotic translation initiation factor 3, subunit 10 (theta) Eif3s10 1.0 0.75 1.09
DnaJ (Hsp40) homolog, subfamily B, member 1 Dnajb1 1.0 0.74 0.94
DnaJ (Hsp40) homolog, subfamily C, member 2 Dnajc2 1.0 0.60 0.81
DnaJ (Hsp40) homolog, subfamily A, member 3 Dnaja3 1.0 0.55 1.53
DnaJ (Hsp40) homolog, subfamily C, member 7 Dnajc7 1.0 0.77 0.99
Heat shock protein 110 Hsp110 1.0 0.61 1.13
Heat shock 70 kDa protein 14 Hsp14 1.0 0.57 0.9
*Absent in control
Nerurkar et al. Journal of Neuroinflammation 2011, 8:64
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Page 8 of 19Figure 2 Effect of HFD and BM on glial cell activation markers. Figure 2 represents microglial activation markers, Iba1 protein levels (A), Aif1/
Iba1 mRNA expression (B) and CD11b mRNA expression (C) as well as astrocyte activation markers, GFAP protein levels (D), GFAP mRNA
expression (E) and S100b mRNA expression (F). The bar graph in Figure 2A and 2D represents the densitometry scan of 17-kD Iba1 and 50-kD
GFAP proteins, respectively. Values for qRT-PCR represent the mean ± SE (n = 4), while those for western blot analysis represent the mean ± SE
(n = 3). Each sample was analyzed in duplicate, in two independent experiments.
a,b,cMean values with common letters do not differ (p < 0·05).
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Page 10 of 19We also observed a significant reduction in stress pro-
teins, such as heat shock protein 110 (Hsp110) and
Dnajb1 (Hsp40) after feeding HFD for 16 weeks. Figure
4 demonstrates the effects of HFD and BM on Hsp110
(Figure 4A), Dnajb1 (Figure 4B), Dnajab3 (Figure 4C) as
well as Eukaryotic translation initiation factor (Eif3s10)
(Figure 4D). HFD significantly reduced mRNA expres-
sion of HSp110 and Dnajb1 by 27% and 21%, respec-
tively, as compared to control (Figures 4A and 4B, p <
0.05), while BM normalized expression of both genes.
Both, HFD and BM had no significant effect on the
expression of Dnajab3 and eif3s10 (Figures 4C and 4D,
respectively).
BM differentially regulates Sirt and FoxO expression in
brains of HFD-fed mice
Feeding HFD has been demonstrated to reduce hippo-
campal levels of stress-resistant gene, Sirt1, involved in
regulating oxidative stress, as well as improving neuro-
nal insults and synaptic plasticity in the brain. Since our
results indicated that BM reduces neuroinflammatory
markers as well as oxidative stress, we further tested the
hypothesis that BM will regulate anti-stress genes such
as Sirt and FoxO in HFD-fed mice. It was observed that
HFD significantly reduced Sirt1 mRNA expression levels
by 20% (p < 0.05) as compared to control mice (Figure
5B). To investigate the correlation between mRNA
expression and protein levels, Sirt 1 protein expression
was analyzed by western immunoblotting. A comparable
trend was also observed wherein the brain Sirt protein
levels were reduced by 25% (p < 0.05) (Figure 5A) in
HFD-fed mice as compared to control mice. Feeding of
BM normalized both, Sirt1 mRNA expression as well as
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Page 11 of 19protein levels (Figures 5B and 5A, respectively). Simi-
larly, the mRNA expression of mitochondrial Sirt iso-
f o r m ,S i r t 3 ,w a sn o n - s i g n i f icantly reduced by 11% in
HFD-fed mice as compared to control mice (Figure 5C).
Changes in Sirt3 mRNA expression by qRT-PCR were
similar to those observed by microarray analysis (Table
2). Interestingly, BM not only normalized the HFD-asso-
ciated reduction of Sirt3 mRNA expression but also up-
regulated it by 20% (p < 0.05) above that of control
mice (Figure 5C).
Besides Sirt, resistance to oxidative stress is also gov-
erned by FoxO proteins. In our study, HFD had no sig-
nificant effect on FoxO1 mRNA expression (Figure 5D).
However, we observed a significant increase in FoxO3a
expression by more than 2.5-fold (Figure 5E, p < 0.05)
as compared to control, which was normalized in mice
fed HFD with BM.
BM normalized plasma antioxidants and reduced systemic
inflammation
Overall, the effect of BM and HFD on plasma oxidative
stress biomarkers demonstrated a pattern similar to
that observed in the brain. Figure 6A, indicated a 250%
increase of plasma SOD levels in HFD-fed mice com-
pared to control and 220% increase compared to mice
fed HFD with BM (p < 0.05). Both, plasma catalase
and GSH were significantly reduced in HFD-fed mice,
while GPX was significantly increased as compared to
control mice (Figures 6B, C and 6D, respectively).
Feeding HFD with BM normalized plasma catalase,
GPX and GSH to control levels (Figure 6A-6D). Simi-
lar to brain, plasma CAT/SOD ratios were significantly
reduced by 40-60% with HFD feeding as compared to
control and HFD + BM fed mice, respectively (Figure
6E, p < 0.05). Plasma GPX/SOD remained unchanged
in all groups (Figure 6F).
Low-grade systemic inflammation plays an important
role in the development of metabolic abnormalities
including obesity, diabetes and cardiovascular diseases
and may impact BBB integrity in HFD-fed mice
[2,31-33]. We therefore investigated the effects of HFD
and BM on peripheral inflammatory markers using a
cytokine antibody array. As expected, HFD was observed
to significantly increase IL-12 and interferon g (IFNg)
levels with a concomitant increase in IL-6 and IL-9
levels as compared to the control mice (Figure 7A, p <
0.05). These pro-inflammatory cytokines were normal-
ized in mice fed HFD with BM (Figure 7A). Although
HFD was also seen to significantly increase IL-5, IL-10
and IL-13, these anti- inflammatory cytokines were
further increased by feeding BM above that of control
and HFD-fed mice (Figure 7A, p < 0.05). Additional
inflammatory molecules such as tumor necrosis factor a
(TNFa), soluble TNF receptor II (sTNFRII), exotaxin-2,
lymphotactin, IL-17 and IL-1b were increased by157 to
1000% (Figure 7B, p < 0.05), along with 200 to 400%
increases in monocyte chemoattractant protein 1
(MCP1), MCP-5, macrophage colony-stimulating factor
(MCSF), macrophage inflammatory protein-1a (MIP-
1a) and regulated on activation, normal T expressed
and secreted (RANTES), member of IL-8 family of cyto-
kines (Figure 7C, p < 0.05) in HFD-fed mice as com-
pared to control animals. Mice fed HFD with BM
demonstrated significantly lower cytokine levels as com-
pared to HFD-fed mice (Figures 7B and 7C, p < 0.05).
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The quantity and diversity of the phenolic constituents
in the BM extracts were analyzed to provide a chemical
fingerprint for future comparison. Qualitative analysis
was initially undertaken to obtain a profile of the extract
using TOF-MS to obtain high-resolution mass spectro-
metric data. The sample was analyzed in both positive
and negative modes (Figures 8A and 8B, respectively) to
identify marker ions, necessary for subsequent standar-
dization. Seventeen prominent ions in the chromato-
gram were identified (Table 3) that can be used for
comparative purposes in future studies. Compounds
previously identified in the BM extract were quantitated
using MRM on a QQQ-MS (Table 4). Individual com-
pounds were identified by analysis of the LCMS chro-
matograms based on comparison with the retention
times, ionization patterns, and fragmentation patterns of
standards. Of the standards analyzed, catechin was the
most abundant polyphenol (3%, w/w of the BM metha-
nolic extract dry weight) followed by quercetin (0.62%,
w/w), trans-chalone and caffeine (0.3 and 0.25%, w/w,
respectively) (Table 4). Caffeic acid, gallic acid and fla-
vones were identified at less than 0.01%, w/w in BM
methanolic extracts (Table 4). Future studies are tar-
geted to identify the undetermined peaks and the exact
structure-activity relation of these fractions.
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Considerable attention has been focused on the effects
of HFD on activation of hypothalamic inflammatory
responses [13,34-37]. However, earlier efforts were
directed mostly towards the role of neuroinflammation
on leptin and insulin resistance in the hypothalamus
that may disrupt satietogenic and adipogenic responses
to maintain a healthy body mass [38]. More recent
advances suggest a role for HFD-induced neuroinflam-
mation in impaired cognition and memory as well as
neurodegenerative diseases such as dementia and Alz-
heimer’s disease [39,40]. Although systemic or periph-
eral stress and inflammation may play a role in
disrupting BBB, the brain, specifically the glial cells are
capable of initiating an innate and local immune
response including release of cytokines and ROS species
that might be detrimental to neuronal health and
ultimately reduce synaptic plasticity leading to cognitive
impairment [41-43]. HFD-associated neuroinflammation
is a complex process involving a multitude of pro- and
anti-inflammatory molecules thereby requiring novel
therapeutic approaches that will ameliorate not only
obesity-associated metabolic perturbations, but also
neuroinflammation.
BM protects brain from HFD-induced neuroinflammation
and glial cells activation
Glial cells, including astrocytes and microglia are key
mediators of neuroinflammation. Hypothalamic inflam-
mation in response to dietary insults such as saturated
fatty acids is a result of activated microglial cells that
increase the release of pro-inflammatory cytokines such
as IL-16 [30,31,44]. Increased levels of Iba1 and GFAP
indicate activation of resident microglial cells and
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Page 14 of 19astrocytes, respectively, possibly leading to the increased
levels of IL-16 and IL-22 mRNA expression observed in
the brains of HFD-fed mice. Neuroprotective effects of
BM is indicated by reduced glial cells activation as well as
normalized IL-16 and IL-22 mRNA levels in brains of
mice fed HFD with BM. Similarly, neuroprotective effects
of BM were also evident from a recent study which
demonstrated that BM attenuated global cerebral ische-
mia-associated oxidative stress and normalized short-
term memory and motor function in diabetic mice [45].
BM regulates peripheral and neuroinflammatory cross-
talk by modulating BBB
Increased expression of IL-22 in the brains of HFD-fed
mice may indicate not only glial cells activation, but also
the presence of activated Th17 cells since IL-22 can be
secreted by active CD4+ Th17 cells [46-50]. Although
brain is considered as an “immune privileged” organ,
studies now indicate that brain can demonstrate an
innate immune response to systemic infections and cer-
ebral injury since activated Th17 cells can transmigrate
through an intact BBB [51]. Alternatively, peripheral or
systemic inflammation can contribute to maintaining
glial cells activation by modulating BBB [2,31-33].
Recent studies have demonstrated that obesity can selec-
tively modulate and promote the expansion of specific
lineage of Th17 cells resulting in systemic inflammation
[52]. The major cytokines that arise from T-helper cell
(Th1) and Th17 CD4(+) T-cell differentiation consist of
IFNg as well as IL-17 and IL-22. BM reduced systemic
inflammation by reducing secretion of plasma pro-
inflammatory cytokines, INFg and IL-17 along with
TNFa, exotaxin-2, lymphotactin and IL-1b in mice fed
HFD with BM. Interestingly, BM upregulated specific
Th2 cytokines IL-5, IL-10 and IL-13, which have been
demonstrated to protect obesity-associated inflammation
[53]. In contrast, Th2 cytokines such as IL-4 is known
to exacerbate HFD-associated hypothalamic inflamma-
tion and weight gain [2]. However, we did not observe
any significant differences in IL-4 secretion in mice fed
HFD with or without BM.
Although it is unclear as how exactly the activated T
cells migrate across the BBB, systemic inflammatory
molecules such as MCP1 has been shown to disrupt
BBB integrity [22], while MIP-1a may promote transen-
dothelial migration of T cells [23] and M-CSF is indica-
tive of glial cells activation [54]. In our studies,
increased levels of plasma MCP-1, MIP-1a and M-CSF
may indicate a potential threat to BBB integrity during
overnutrition. A compromised BBB permeability was
evident by the presence of increased Evans blue dye in
the brains of mice fed HFD, which was significantly
lower in mice fed HFD with BM, possibly due to reduc-
tion in plasma levels of MCP-1, MIP-1a and M-CSF.
It is however, interesting to note that BBB does not
necessarily inhibit lymphocyte entry, but actively restrict
the entry of resting T cells and allow transmigration of
only recently activated T cells ([55] and references
within). Besides IL-22, secretion of IL-17 by activated
Table 3 Major Ions observed during Time-of-Flight
analyses based on Figures 8A and 8B
Peak # Retention Time (min) m/z Polarity Species
1 2.7 394.35 Positive Not Determined
2 4.1 340.261 Positive [M+H]
+
3 4.8 566.31 Positive [M+H]
+
4 5.1 966.0 Negative Not Determined
5 5.7 419.33 Positive [M+H]
+
6 5.7 909.45 Negative Not Determined
7 6.0 419.33 Positive [M+H]
+
8 6.0 327.22 Positive [M+H]
+
9 6.5 325.20 Negative [M-H]
-
10 10.2 496.34 Positive Not Determined
11 10.7 4317.34 Positive Not Determined
12 10.8 293.21 Positive [M+H]
+
13 13.8 227.23 Negative Not Determined
14 14.7 282.28 Positive [M+H]
+
15 14.8 331.29 Positive [M+H]
+
16 15.3 367.27 Negative Not Determined
17 15.7 255.23 Negative Not Determined
18 15.9 281.25 Negative Not Determined
Table 4 Quantitative analysis of a methanolic BM extract using LC-QQQ-MS
Abundance % (w/
w)
Abundance % (w/
w)
MRM Transition (Precursor or
Product)
Polarity Fragmentor Collision
Energy
Retention
Time
trans-Chalcone 0.30 209/103 positive 130 40 10.2
Flavone < 0.01 223/129 positive 130 40 8.4
Caffeine 0.25 195/123 positive 130 40 2.2
Gallic acid < 0.01 169/125 negative 90 15 0.9
Quercetin 0.62 301/151 negative 90 15 5.5
Caffeic acid < 0.01 179/135 negative 100 20 2.5
Catechin 3.02 289/245 negative 100 20 2.2
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BBB endothelial cells and alter BBB permeability [48]
and promote transmigration of activated Th17 cells into
the brain [49,50]. We observ e dt h a tH F Da l s oi n d u c e d
the expression of IL-17 cognate receptor, IL-17RB. Stu-
dies have demonstrated that IL-17 can promote neuro-
nal injury through IL-17-IL-17R interactions [56]. It is
important to note that since whole brains were dissected
after perfusion of the mice with cold PBS, release of
inflammatory cytokines through the blood into the brain
is expected to be negligible. Reduced Evans blue dye in
the brain and normalization of IL-22 and IL17R mRNA
expression in the brains of mice fed HFD with BM
strongly suggests that BM restores BBB permeability as
well as prevents transmigration of Th17 cells. However,
modulation of BBB permeability, thereby leading to
immune cell trafficking by BM, requires further
investigation.
Antioxidative potential of BM
Zhang et al. offer important insights into the link
between overnutrition and activation of inflammatory
and stress pathways in the hypothalamus [36]. Hypotha-
lamic neurons generally enriched with inactive IKKb/
NF-B, become markedly activated due to overnutrition
and consequently generate hypothalamic stress [36] and
produce free radicals by activated microglial cells [57].
Similar to studies of Zhang et al. [36], our data indicates
that HFD reduced the expression of stress proteins
(Hsp110 and Dnajb1), with a concomitant increase in
NF-B1 mRNA expression as compared to control
mice. HFD-induced oxidative stress and overproduction
of reactive oxygen species (ROS) can lead to synaptic
dysfunction and cognitive decline in mice [34,36,58].
Increased SOD activities observed in HFD-fed mice are
indicative of adaptive mechanisms in response to
increased levels of ROS [29], generating H2O2 that can
be further detoxified by either catalases or GPx. In our
s t u d y ,H F D - f e dm i c ew e r eu n a b l et od e t o x i f yi n c r e a s e d
production of H2O2 as evident by significant reduction
in both, catalase and GPx enzyme activities. Endogenous
GSH also plays an important role in detoxifying ROS.
Lower GSH levels in brains of HFD-fed mice is indica-
tive of ROS-induced tissue damage which could be pos-
sibly due to reduced capacity to cope with oxidative
damage as reflected by a lower CAT/SOD and GPX/
SOD ratios. A similar trend in systemic oxidative stress
markers is observed in mice fed HFD, while BM was
noted to reduce plasma SOD and GPX and normalize
plasma GSH, catalase as well as CTA/SOD and GPX/
SOD ratios.
Our results are similar to those demonstrated with water
extracts of BM fruits that prevented acetaminophen-, furo-
semide- and chloroform-induced hepatotoxicity in mice
[59], by attenuating the production of lipid peroxidation
product, malondialdehyde (MDA) and increasing hepatic
glutathione (GSH), indicative of its antioxidant properties
[59]. BM seed extracts also improve antioxidant profile in
streptozotocin (STZ)-induced diabetic male Wistar rats by
modulating GSH, catalase, GPx and glutathione-s-transfer-
ase enzyme activities [60]. BM was observed to normalize
both, anti-oxidative enzymes as well as stress proteins in
brains of mice fed HFD with BM. Brain Hsp are involved
in synaptic plasticity and may be involved in protecting
brain either against stress-induced apoptosis [61] or
unfolded protein response (UPR) [62]. In our study,
increase in Hsp70 and Dnajb1 proteins by BM may sug-
gest attenuation of either neuronal stress or UPR, induced
by HFD.
Modulation of Sirt and FoxO expression by BM
NF-B, a “master inflammatory switch” is “turned on”
by HFD [36] and “turned off” by the “master metabolic
switch”, Sirtuin 1 (Sirt1) [63]. Modulation of neurode-
generative diseases by Sirt1 is associated with improve-
ment of oxidative stress and neuronal inflammation
[64]. Feeding of HFD to Sprague-Dawley rats reduced
Sirt1 levels in hippocampus and cerebral cortex due to
increased oxidative stress [12]. The observed 25% reduc-
tion of Sirt1 protein in brains of HFD-fed mice is lower
than the 81% reduction reported by Wu et al. [12] in
the hippocampus and cerebral cortex of HFD-fed rats.
The observed differences in the levels of Sirt inhibition
in our study and that of Wu et al. [12] is possibly due
to the fact that regulation of Sirt1 expression differs in
various brain regions and is mostly up-regulated in the
hippocampus and cerebral cortex [65]. While Wu et al.
[12] analyzed the effects of HFD in the hippocampus
and cerebral cortex, our study was conducted using an
aliquot of the whole brain rather than hippocampus or
cerebral cortex. While, HFD had no effect on Sirt3, BM
induced a minimal but significant increase in Sirt3
mRNA expression. Sirt3 is a mitochondrial deacetylase
and the murine Sirt3 transcript codes for three protein
variants [66]. The exact role of BM-induced Sirt3
mRNA expression, as well as the protein variants
requires further investigation.
Sirt is a critical regulator of FoxO proteins in response
to oxidative stress [67,68], which are now emerging as
an important target in mechanisms of neurodegenerative
diseases. Increased levels of neuronal FoxO3a have been
associated with neuronal cell death [69] as well as oxida-
tive stress [70]. In our study, HFD-induced increase in
FoxO3a may have contributed to either increased oxida-
tive stress or to microglial cells activation via NF-B. It
is possible that concomitant increase in Sirt1 and reduc-
tion in FoxO3a may have lowered oxidative stress and
NF-B expression in mice fed HFD with BM [12].
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Immunomodulatory potential of BM was evident by dif-
ferential secretion of Th1, Th2 and Th17-associated
pro-and anti-inflammatory cytokines in mice fed HFD
with BM. In our studies, increased secretion of anti-
inflammatory cytokine, IL-10 by BM is similar to that
observed by Manabe et al who also demonstrated an
increased secretion of IL-10, and transforming growth
factor b (TGF-b) in healthy rats fed BM for three weeks
[71] along with in vitro increase of IL-10 secretion in
human monocytes, THP-1 [71]. Similarly, the inhibitory
effects of BM on IL-6, IL-1b and TNF-a observed in
our study was also demonstrated in previous in vitro
studies, wherein BM increased IL-10 production and
inhibited IL-1b, IL-6 and tumor necrosis factor alpha
(TNF-a) levels in lipopolysaccharide (LPS)-stimulated
murine peritoneal macrophages, suggesting a prophylac-
tic effect on LPS-induced inflammation [21].
Chemical components of BM
BM is a mixture of various flavanoids, bitter and non-
bitter cucurbitane, triterpene aglycones and/or glyco-
sides, imparting antioxidant properties. Our studies
demonstrate the presence of marker polyphenols such
as catechin, quercetin, trans-chalone and caffeine, while
Caffeic acid, gallic acid and flavones were present at
lower concentrations. Similarly, Horax et al have also
demonstrated catechin as a major polyphenol in peri-
carp and seeds of BM [72].
To our knowledge our study is the first to demon-
strate a neuroprotective effect of BM in mice fed HFD,
which demonstrated significant reduction in BBB leak-
age, neuroinflammatory cytokines mRNA expression
(IL-16, IL-22), glial cells activation and NF-B1 expres-
sion, as well as improved oxidative stress in the brains
of mice fed HFD with BM, along with amelioration of
peripheral oxidative stress and systemic inflammation.
Overall, induction of oxidative stress, modulation of
longevity and ER-chaperone genes, as well as induction
of interleukins and NF-B1 by HFD supports the role of
obesity in the pathogenesis of neuroinflammation. Our
study also presents novel properties of BM that offer
unique treatment options to ameliorate not only obesity,
hyperglycemia and hyperlipidemia, but also to prevent
HFD-induced neuroinflammation associated with micro-
glial cells activation and lymphocyte infiltration. This
study also demonstrates ameliorating effects of BM on
systemic inflammation and modulation of Th1, Th2 and
Th17 immunity. Over the long run, studies such as ours
can help to develop effective nutritional strategies to
update and/or modify dietary recommendations and
nutritional policies for “healthy aging”. Future studies
are warranted to identify the neuro-immunomodulatory
and anti-inflammatory components of BM.
Conclusions
As expected, HFD-fed mice demonstrated a reduction in
Sirt1 protein levels with an increase in oxidative-stress
and a simultaneous induction of FoxO3a, NF-B1 and
IL-16 mRNA expression. HFD was further observed to
activate resident glial cells and increase proinflammatory
cytokines, IL-16 and IL-22 possibly via NF-B mediated
mechanisms. BM significantly increased Sirt3 mRNA
expression and normalized Sirt1 protein levels as well as
oxidative stress in mice fed HFD with BM, suggesting
antioxidant effect of BM. In addition, reduction and
normalization of Iba1, GFAP, NF-B1, IL-16 and IL-22
mRNA expression by BM, further suggests that BM
inhibits microglial cells activation possibly by Sirt-NF-
B interactions. Our studies also demonstrate that BM
can prevent not only HFD-induced neuroinflammation
characterized by BBB disruption, lymphocyte transmi-
gration across BBB and microglial cells activation, but
also systemic stress and inflammation. Strategies to pre-
vent not only weight gain, but also obesity-associated
brain dysfunction are limited. BM offers a novel adjunct
therapeutic approach to ameliorate obesity-associated
peripheral inflammation and neuroinflammation.
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